Orlando, Fla.—Dexmedetomidine proved superior to propofol with respect to all time-dependent outcomes, a meta-analysis has shown.
Enrico M. Camporesi, MD, a professor emeritus of surgery at the University of South Florida, in Tampa, and his colleagues screened 804 studies, of which 11 were included in the final analysis (1,184 patients). Patients who received dexmedetomidine demonstrated a significant reduction in time to extubation (standardized mean difference,